a study on Lung Cancer
The primary purpose of the study is to compare the antitumor activity of LDK378 vs. chemotherapy in patients previously treated with chemotherapy (platinum doublet) and crizotinib.
A Phase III, Multicenter, Randomized, Open-label Study of Oral LDK378 Versus Standard Chemotherapy in Adult Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer Who Have Been Treated Previously With Chemotherapy (Platinum Doublet) and Crizotinib
Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer, ALK, LDK378 Docetaxel Ceritinib Pemetrexed Crizotinib
Open to people ages 18 years and up
© The Regents of the University of California